Evidence map›Paper›PMID 37867479›Full record

ArticleTurkish journal of ophthalmology2023

Combining Perfluorobutylpentane (F

Stylianos A Kandarakis, Petros Petrou, Spyridon Doumazos, Konstantina Chronopoulou, Leonidas Doumazos, Ioannis Halkiadakis, Ilias Georgalas

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Stylianos A KandarakisNational and Kapodistrian University of Athens, G. Gennimatasgeneral Hospital, 1st Department of Ophthalmology, Athens, Greece.ORCID 0000-0003-2912-7438
Petros PetrouNational and Kapodistrian University of Athens, G. Gennimatasgeneral Hospital, 1st Department of Ophthalmology, Athens, Greece.ORCID 0000-0002-7358-1251
Spyridon DoumazosNational and Kapodistrian University of Athens, G. Gennimatasgeneral Hospital, 1st Department of Ophthalmology, Athens, Greece.ORCID 0000-0002-1674-1984
Konstantina ChronopoulouNational and Kapodistrian University of Athens, G. Gennimatasgeneral Hospital, 1st Department of Ophthalmology, Athens, Greece.ORCID 0000-0002-7130-6002
Leonidas DoumazosNational and Kapodistrian University of Athens, G. Gennimatasgeneral Hospital, 1st Department of Ophthalmology, Athens, Greece.
Ioannis HalkiadakisAthens Eye Hospital, Ophthalmiatrion Athinon, Athens, Greece.ORCID 0000-0001-8403-7721
Ilias GeorgalasNational and Kapodistrian University of Athens, G. Gennimatasgeneral Hospital, 1st Department of Ophthalmology, Athens, Greece.ORCID 0000-0002-6171-5865
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Our aim was to perform a perfluorobutylpentane (F Materials and Methods: Eight patients who previously underwent pars plana vitrectomy with SO tamponade due to retinal detachment were selected. Removal of SO was performed on average 10 months after initial surgery. All patients developed glaucoma with evidence of SO remnants in the anterior chamber (AC) and angle. Removal of the remaining SO with F Results: All patients had uneventful surgery with no major complications 12 months postoperatively. A marked reduction of SO remnants in the AC and angle was observed in all cases after surgery. There was a 60.9% decrease in mean IOP 12 months postoperatively (p<0.05) and the need for glaucoma medication was lower in all patients (mean topical medicines: 4 preoperatively vs. 0.75±0.89 postoperatively; p<0.05). Endothelial cell density showed no significant change (mean 2012±129 cells/mm Conclusion: F

Indexed as

GlaucomaGlaucoma Drainage ImplantsFluorocarbonsHumansPilot ProjectsSilicone OilsFluorocarbonsperfluorobutylpentaneSilicone OilsGlaucoma drainage devicesperfluorobutylpentane (F4H5)silicon oil-induced glaucomasilicon oil remnantssilicon oil removal

Identifiers

PMID37867479
PMCPMC10599334
OpenAlexW4387781743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.